Investment Summary

Micrima has developed an imaging system that exploits differences in permittivity – the ability of a substance to store electrical energy in an electric field – to identify and locate lesions in breast tissue. The company intends to develop and commercialise a new Breast Imaging System (MARIA) aimed at radically improving breast cancer detection and survival rates through the provision of much safer, more frequent, more comfortable and less expensive breast checks from a much younger age, and delivered within the local community.